These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6690689)

  • 1. (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase.
    Bey P; Fozard J; Lacoste JM; McDonald IA; Zreika M; Palfreyman MG
    J Med Chem; 1984 Jan; 27(1):9-10. PubMed ID: 6690689
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.
    McDonald IA; Lacoste JM; Bey P; Palfreyman MG; Zreika M
    J Med Chem; 1985 Feb; 28(2):186-93. PubMed ID: 3968682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
    Zreika M; McDonald IA; Bey P; Palfreyman MG
    J Neurochem; 1984 Aug; 43(2):448-54. PubMed ID: 6736960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Z)-2-(2,4-Dichlorophenoxy)methyl-3-fluoroallylamine (MDL 72638): a clorgyline analogue with surprising selectivity for monoamine oxidase type B.
    McDonald IA; Palfreyman MG; Zreika M; Bey P
    Biochem Pharmacol; 1986 Jan; 35(2):349-51. PubMed ID: 3753647
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vivo effects of (E)-2-(3',4'-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat. Selective inhibition of semicarbazide-sensitive amine oxidase in vascular and brown adipose tissues.
    Elliott J; Callingham BA; Barrand MA
    J Pharm Pharmacol; 1989 Jan; 41(1):37-41. PubMed ID: 2565962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV; Heikkila RE
    Life Sci; 1986 Apr; 38(16):1459-62. PubMed ID: 3084895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
    Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P
    J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative ex vivo inhibitory effects of (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine (MDL 72145) on amine oxidase activities in the rat.
    Lyles GA; Marshall CM; Flucker CJ
    Biochem Pharmacol; 1989 Sep; 38(17):2937-40. PubMed ID: 2775316
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
    Boor PJ; Nelson TJ
    Toxicology; 1980; 18(2):87-102. PubMed ID: 7256782
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.
    Fozard JR; Palfreyman MG; Robin M; Zreika M
    Br J Pharmacol; 1986 Jan; 87(1):257-64. PubMed ID: 3082400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological evaluation of 2,4-difluorobenzyldimethylsilylmethanamine, a new highly selective inhibitor of monoamine oxidase-B.
    Danzin C; Zreika M; Marchal P; Petty M; Collard JN; Schirlin D
    Biochem Soc Trans; 1994 Aug; 22(3):768-73. PubMed ID: 7821682
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and monoamine oxidase inhibitory activities of alpha-allenic amines in vivo and in vitro. Different activities of two enantiomeric allenes.
    Sahlberg C; Ross SB; Fagervall I; Ask AL; Claesson A
    J Med Chem; 1983 Jul; 26(7):1036-42. PubMed ID: 6864731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA; Kalnina IE; Moskvitina TA; Gorkin VZ
    Biochem Pharmacol; 1977 Jun; 26(11):1059-63. PubMed ID: 18152
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: potential prodrugs of (R)- and (S)-nordeprenyl.
    Flaherty P; Castagnoli K; Wang YX; Castagnoli N
    J Med Chem; 1996 Nov; 39(24):4756-61. PubMed ID: 8941389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues.
    Nelson TJ; Boor PJ
    Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate selectivity of type A and type B monoamine oxidase in rat brain.
    Kinemuchi H; Wakui Y; Kamijo K
    J Neurochem; 1980 Jul; 35(1):109-15. PubMed ID: 6778959
    [No Abstract]   [Full Text] [Related]  

  • 19. Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates.
    Ding CZ; Lu X; Nishimura K; Silverman RB
    J Med Chem; 1993 Jun; 36(12):1711-5. PubMed ID: 8510099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some pyridazinylacetic acid derivatives as a novel class of monoamine oxidase-A inhibitors.
    Khattab SN; Bekhit AA; El-Faham A; El Massry AM; Amer A
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1717-21. PubMed ID: 19043245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.